Skip to main content

Capturing pricing opportunity in speciality chemicals through automation

15th November 2021

Submitted by:

Andrew Warmington

Robert Smith of Pricefx looks at how a sector that is not traditionally price-driven can cope in a world of price volatility

Over the past year, dramatic market changes due to a cascade of unique events, notably the COVID-19 pandemic, the Suez Canal obstruction and the Colonial Pipeline ransomware attack, have impacted pricing - and subsequently, profits - across a myriad of industries. While these occurrences have received worldwide media attention, looking at them as outliers would miss the point: in today’s highly interconnected world, market volatility that in turns affects prices is the norm.

To a great extent, speciality chemical producers would see this volatility as the domain of commodity products. There is an inherent desire in speciality chemicals to resist frequent price changes and to avoid any connection between price and cost. Certainly, variations in supply and demand put pressure on pricing models and may impact product pricing, but other opportunities in pricing exist for the producer and seller.

The speciality product has differentiation in value that needs to be understood and protected. There is a need for a systemised approach to value that enables this differentiation to be rewarded through price. Additionally, in today’s world of ever increasing data, there is an opportunity to leverage certain kinds of data to develop an improved understanding of value-based segmentation and customer willingness to pay.

Automation in pricing software can support both of these areas to enable proper value realisation and a significant uplift in profitability. This article will briefly explore these opportunities to better understand how the speciality chemical company can benefit from pricing software.

Understanding value drivers

The speciality chemical value proposition centres on products that are differentiated and create unique value for customers. Understanding this differentiation by market and customer typically involves a depth of understanding that may take many years of experience to understand.

For those companies who have built an in-depth understanding of customer value, it is important to consider how to apply that to pricing and to ensure the pricing is not undermined by aggressive procurement professionals attempting to reframe the product as a commodity for competitive purposes. In such situations, having a pricing infrastructure that supports the documentation of value drivers and automatically applies it to quoting and pricing activities is critical to sustain value.

Leveraging existing data

Some speciality producers may feel they lack the in-depth understanding of differential value described above or are unable or unwilling to invest the resources to build the deep understanding of differentiation needed to price products in accordance with the value realised by their customers. In such cases, there is another way to get to this understanding. The key to it can be found in the combination of pricing data and pricing software.

Current price optimisation capabilities can leverage existing pricing data to determine value-based market segments and customer willingness to pay within such segments. When combined with the above-mentioned capabilities to apply these insights automatically to quoting and pricing activities, a robust engine exists to improve understanding and capture of customer value, resulting in increased margins.

Speciality chemicals have unique physical properties that differentiate them from other chemicals on the market. With automation tools, producers have a better understanding of the value their products add to their customers’ business. By learning what customers value and what they are willing to pay for - value-based pricing versus cost-based pricing - leaders can set the right target price for each product for each customer.

Sales teams can also benefit from the use of automation pricing tools, in that the tools guide sales teams and provide a target range that permits some flexibility. Management can flex the incentive scheme’s emphasis on price or volume, depending on market conditions and asset utilisation.

Best practices for implementation

A pricing strategy will not succeed without ongoing support from top management. And, while it is natural that any change will have promoters and detractors at the onset, it is important for management to bring the team together behind the vision and reinforce critical pricing behaviour with role modelling and the other incentives.

Ahead of implementing automation software, executives should consider three priorities:

* Sequence the programme: Not everything needs to happen at once. Prioritisation will be essential, not only to direct focus but also to draw lessons in early stages that can be applied throughout

* Focus on early wins: As with any new initiative, putting a premium on measurable results early can improve the case for change. Momentum builds as detractors see the benefits of new programmes

* Make it tangible and practical: None of this will work unless the sales force buys in and changes its behaviour.

Most companies will require a significant investment in training, tools and new processes to ensure a successful rollout and ongoing change There is never a bad time to improve pricing capabilities through AI-powered automation, but there is certainly no better time than now, especially for an industry like speciality chemicals that has been slow to evolve its pricing model.

Speciality chemicals producers who do not act may find themselves struggling to maintain value differentials in pricing as geopolitical and environmental tumult continue. Those who follow the formula for pricing success - pricing to value, adopting price optimisation and realigning sales incentives - can outperform the market and maintain a healthy bottom line.

Contact:

Robert Smith

Industry Advisor

Pricefx

[email protected]

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington